Hormonally responsive bovine oviductal organoids recapitulate native oviductal secretions and enhance sperm capacitation

This study establishes hormonally responsive bovine oviductal organoids that accurately mimic the native oviduct's phase-specific molecular signatures and functional secretions, thereby enhancing sperm capacitation and offering a sustainable platform for advancing assisted reproduction technologies.

The Gist

The Big Idea: Building a "Smart" Mini-Factory

Imagine the oviduct (the tube connecting the egg to the uterus) as a highly sophisticated, high-tech factory. Its job isn't just to let things pass through; it actively changes the environment to help sperm meet an egg and start a family.

The problem is that this factory is incredibly complex. It changes its "mood" and its "output" depending on the time of the month (the hormonal cycle). Scientists have tried to copy this factory in a lab dish for years, but the old models were like flat, 2D drawings of a building—they lacked the 3D structure and the ability to change with the seasons.

This paper introduces a breakthrough: The scientists successfully grew 3D "organoids" (miniature, living models) of the cow oviduct. Think of these organoids as tiny, self-assembling, living bubbles that behave exactly like the real thing.

How They Did It: The "Seasonal" Switch

The key to this study was teaching these tiny bubbles to understand the difference between Spring (Follicular Phase) and Autumn (Luteal Phase).

1. The Setup: They took cells from cow reproductive tracts and let them grow into these 3D bubbles in a special gel.
2. The Hormone Switch:
   • Spring Mode (Estradiol): They added a hormone called Estradiol. This told the bubbles, "It's time to get ready for a baby!" The bubbles started acting like they were in the pre-fertilization phase.
   • Autumn Mode (Progesterone): They added Progesterone. This told the bubbles, "The egg is fertilized; let's settle down and support the growing family." The bubbles switched to a post-fertilization mode.

The Secret Sauce: The "Secretions"

The most important part of the oviduct isn't the wall itself; it's the liquid it secretes (the "factory output"). In the real body, this liquid is a magical cocktail of proteins that helps sperm swim better and get ready to fertilize an egg.

• The Old Way: Scientists used to try to collect this liquid from slaughtered animals. But it was messy, inconsistent, and ran out quickly.
• The New Way: Because these organoids are 3D bubbles with a hollow center (a lumen), they trap their own secretions inside. The scientists could gently pop the bubbles and harvest a pure, concentrated sample of this "magic liquid" (called Organoid-Derived Secretions or ODS).

The Analogy: Imagine the old method was like trying to catch rainwater from a leaky roof using a bucket—it's dirty and unpredictable. The new method is like having a high-tech water filtration system that produces pure, consistent rainwater on demand, exactly when you need it.

The Proof: Does It Actually Work?

The scientists wanted to know: Does this fake liquid actually help sperm?

They took frozen bull sperm (which are usually a bit sleepy) and put them in a dish with the "Spring Mode" liquid from the organoids.

• The Result: The sperm woke up! They became more active, their membranes became more fluid (a sign of readiness), and they were much more likely to undergo the "acrosome reaction" (the process of breaking through the egg's shell).
• The Comparison: This effect was just as good as using liquid taken from a real, live cow.

Why This Matters: A Game Changer for Reproduction

This study is a huge deal for a few reasons:

1. It's a Perfect Copy: The organoids didn't just look like the oviduct; they thought and acted like it. They changed their genetic code and protein production based on the hormones, just like a real body does.
2. It's Sustainable: Instead of relying on slaughterhouse materials (which vary wildly in quality), scientists now have a renewable, ethical, and consistent source of this vital fluid.
3. Better Babies (and Cows): By understanding exactly what the oviduct does, we can improve Assisted Reproductive Technologies (ART). This means better success rates for IVF in humans and better breeding outcomes for livestock.

The Bottom Line

The scientists built a living, breathing, hormone-responsive mini-oviduct in a dish. They proved that this tiny model produces a "secret sauce" that wakes up sperm and prepares them for fertilization, just like nature intended. It's like finally cracking the code to the factory's control panel, allowing us to replicate its magic in a clean, controlled, and reliable way.

Technical Summary

1. Problem Statement

The oviduct provides a dynamic, hormonally regulated microenvironment essential for fertilization and early embryo development. Its epithelium secretes a complex mixture of proteins, lipids, and metabolites that fluctuate between the follicular (estrous) and luteal phases, driven by estradiol (E2) and progesterone (P4).

• Current Limitations:
  • 2D Cultures: Traditional two-dimensional bovine oviductal epithelial cell cultures lack the necessary apical-basal polarity and luminal compartmentalization to mimic in vivo secretion.
  • Ex Vivo Fluids: Direct collection of oviductal fluid from slaughterhouse tissue suffers from high donor variability, degradation of secretions post-collection, and ethical/practical constraints, limiting reproducibility.
  • Existing 3D Models: Previous 3D models (e.g., spheroids) often lack long-term expandability, lose secretory profiles rapidly, or utilize an "apical-out" orientation that complicates the isolation of pure luminal secretions without medium contamination.

2. Methodology

The study established and characterized bovine oviductal epithelial organoids to model the oviductal microenvironment in vitro.

• Organoid Derivation:
  • Epithelial cells were isolated from the infundibular–ampullar region of bovine reproductive tracts using trypsin-EDTA digestion.
  • Cells were embedded in Matrigel to form 3D cystic structures with an apical-in orientation (lumen facing inward), allowing for the accumulation of secretions.
  • Fibroblasts were removed via differential adhesion.
• Hormonal Stimulation:
  • Organoids were treated for 4 days to mimic specific phases of the estrous cycle:
    • Follicular Phase (E2): 10 nM Estradiol.
    • Luteal Phase (mP4): 2 days of 10 nM E2, followed by 2 days of 1 nM E2 + 1 µM Medroxyprogesterone acetate (mP4) + 1 µM cAMP.
• Secretion Collection (ODS):
  • Organoid-derived secretions (ODS) were harvested by dissolving the Matrigel, washing, and mechanically disrupting the organoids to release luminal contents, which were then centrifuged to remove cellular debris.
• Multi-Omics Analysis:
  • Transcriptomics: RNA-seq was performed on organoid pellets to analyze gene expression. Data was analyzed using DESeq2 and deconvoluted using CIBERSORTx against a mouse single-cell reference.
  • Proteomics: LC-MS/MS (DIA-NN workflow) was used to profile proteins in ODS.
  • Integration: Multi-Omics Factor Analysis (MOFA2) was employed to identify latent factors linking transcriptomic and proteomic data.
• Functional Assays:
  • Sperm Capacitation: Bull sperm were incubated with ODS from Control, E2, and mP4 groups.
  • Readouts: Flow cytometry (membrane fluidity, acrosome reaction, viability), Computer-Assisted Sperm Analysis (CASA) for motility, and Western Blotting for phosphorylation of PKA substrates (pPKA) and tyrosine residues (pTyr).

3. Key Contributions

• First Hormonally Responsive Bovine Oviductal Organoids: The study successfully established a renewable, expandable 3D model that retains the structural polarity and endocrine responsiveness of the native bovine oviduct.
• Phase-Specific Secretome Generation: The model generates distinct, bioactive secretions (ODS) that mimic the molecular composition of the follicular and luteal phases, overcoming the variability of ex vivo fluid collection.
• Mechanistic Linkage: The study provides the first integrated transcriptomic-proteomic evidence that hormone-driven transcriptional programs directly dictate the composition of secreted proteins in the oviduct.
• Functional Validation: It demonstrates that organoid-derived secretions are not just molecularly similar but functionally equivalent to native oviductal fluid, specifically in enhancing sperm capacitation.

4. Key Results

• Structural and Transcriptional Fidelity:

  • Organoids formed polarized cysts expressing epithelial markers (E-cadherin, Laminin) and secretory markers (SOX17).
  • E2 Treatment: Upregulated follicular markers (OVGP1, NTS, OXTR) and pathways related to secretion and extracellular remodeling.
  • mP4 Treatment: Upregulated luteal markers (HP, TGM2, ESR2) and pathways related to extracellular matrix stabilization and metabolic adaptation, while repressing cell-cycle regulators.
  • Transcriptomic profiles showed significant overlap with in vivo bovine oviductal data (Cerny et al., 2015).

• Proteomic Characterization of ODS:

  • ODS shared 83.7–83.9% of their protein content with native early luteal oviductal fluid.
  • E2-ODS: Enriched in secretory proteins (OVGP1, PIP, SELENOM) and lysosomal enzymes, reflecting the pre-ovulatory state.
  • mP4-ODS: Enriched in extracellular matrix regulators (TIMP1, CTSZ) and luteal-phase proteins (HP, TGM2).
  • MOFA Integration: Identified coherent latent factors where Factor 2 correlated with mP4 (redox/metabolism) and Factor 3 with E2 (growth factor signaling/secretion), confirming that transcriptional changes drive secretory output.

• Functional Impact on Sperm:

  • Capacitation: Sperm incubated with E2-ODS showed significantly increased membrane fluidity, acrosome reaction rates, and phosphorylation of PKA substrates and tyrosine residues compared to controls.
  • Comparison: The effect of E2-ODS paralleled that of native preovulatory oviductal fluid (positive control), whereas mP4-ODS had minimal effect, consistent with the post-fertilization luteal phase.
  • Motility: Total and progressive motility tended to increase with E2-ODS.

5. Significance

• Technological Advancement: This platform offers a sustainable, ethically sound, and highly reproducible alternative to animal-derived oviductal fluids for research and clinical applications.
• Assisted Reproductive Technologies (ART): The ability to generate bioactive, phase-specific secretions allows for the refinement of in vitro fertilization (IVF) media. Adding E2-ODS could improve sperm capacitation and fertilization rates in bovine (and potentially human) ART.
• Research Utility: The model enables systematic study of gamete-maternal communication, oviductal pathophysiology, and the effects of environmental toxins on fertility without the confounding variables of in vivo collection.
• Future Directions: The authors suggest future integration with microfluidics to simulate luminal flow and the expansion of this model to study embryo development and interspecies reproductive strategies.